Y G Meng

Research on the SDT technology based on a two-stage structure

M C Xian, Y G Meng, J Y Xie, 2020 .

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.

Leonard, Y G Meng, L. Presta, 1997, Cancer research.

Green fluorescent protein as a second selectable marker for selection of high producing clones from transfected CHO cells.

Y G Meng, Y. Meng, J. Liang, 2000, Gene.

Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.

Y G Meng, Y. Meng, N. Modi, 1999, The Journal of pharmacology and experimental therapeutics.

Generation of a Humanized, High Affinity Anti-tissue Factor Antibody for Use as a Novel Antithrombotic Therapeutic

Y G Meng, L. Presta, R. Kelley, 2001, Thrombosis and Haemostasis.

Immunopolymerase chain reaction using real-time polymerase chain reaction for detection.

Y G Meng, P. Williams, M. Vasser, 2000, Analytical biochemistry.